Oral Manifestations of Systemic Sclerosis
Oral Manifestations of Systemic Sclerosis: Toward the Identification of New Prognostic Markers
Sponsor: University Hospital, Strasbourg, France
Terminated
scleroderma patients were difficult to recruit
Other terminated trials from University Hospital, Strasbourg, France
- Healthy Control Subjects · Apr 2025
- Cystic Fibrosis-related Diabetes · Phase PHASE4 · Jan 2025
- Kidney Transplant Recipients · Nov 2024
- Diagnosed With Uretral Fibroscopy · Sep 2024
- Patients with Colorectal Cancer · Phase NA · Sep 2024
See all terminations from University Hospital, Strasbourg, France
Other Scleroderma, Systemic trials with similar outcome
This NA trial investigates Scleroderma, Systemic and is currently terminated or withdrawn. University Hospital, Strasbourg, France leads this study, which shows 11 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Oct 2021 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
Sep 2020 — Jan 2021 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Sep 2019 — Sep 2020 [monthly]
Recruiting NA
-
Sep 2018 — Sep 2019 [monthly]
Recruiting NA
-
Jun 2018 — Sep 2018 [monthly]
Recruiting NA
-
Oct 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
-
Feb 2017 — Oct 2017 [monthly]
Unknown Status NA
Status: Not Yet Recruiting → Unknown Status
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting NA
First recorded
Jun 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Strasbourg, France
For direct contact, visit the study record on ClinicalTrials.gov .